Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

Medrx

メドレックス

4586 · TSE · Pharmaceutical · 1 article

Financials Consolidated

Revenue¥128m−50.3% year on yearConsolidated · FY12/25

Ordinary profit−¥937mConsolidated · FY12/25

Net profit−¥937mConsolidated · FY12/25

Performance over time

Revenue
¥8.35mFY12/21
¥59.5mFY12/22
¥29.5mFY12/23
¥258mFY12/24
¥128mFY12/25
Ordinary profit
−¥1.07bnFY12/21
−¥1.11bnFY12/22
−¥931mFY12/23
−¥755mFY12/24
−¥937mFY12/25
Net profit (attributable)
−¥1.06bnFY12/21
−¥1.11bnFY12/22
−¥933mFY12/23
−¥807mFY12/24
−¥937mFY12/25
Op. cash flow
−¥924mFY12/21
−¥1.07bnFY12/22
−¥914mFY12/23
−¥803mFY12/24
−¥888mFY12/25

People & pay

Employees, whole group21 peopleFY12/25

Employees, parent company (non-consolidated)20 peopleFY12/25

Average salary¥6.16mFY12/25

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitNet profit (attributable)EPSTotal assetsNet assetsOp. cash flow
FY12/25¥128.08m−50.3% year on year−¥937m−¥937m−¥17.44¥2.16bn¥2.05bn−¥888m
FY12/24¥257.92m+773.3% year on year−¥755m−¥807m−¥18.56¥2.28bn¥2.17bn−¥803m
FY12/23¥29.53m−50.3% year on year−¥931m−¥933m−¥26.82¥2.05bn¥1.92bn−¥914m
FY12/22¥59.48m+612.4% year on year−¥1,112m−¥1,111m−¥43.81¥1.40bn¥1.21bn−¥1,073m
FY12/21¥8.35m−¥1,066m−¥1,060m−¥49.62¥2.11bn¥1.96bn−¥924m

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100XS7V · Japan GAAP. Each figure's years come from one report's five-year summary.

Latest coverage

TSE:4586

Tokyo Brief coverage

All articles loaded · 1 shown

5% holders

Latest disclosed holders and exits below 5%.

1 holder · data through

No stored data for this selection.

Exits below 5%

Exits below 5%
HolderStakeChangePurposeFiling
Growth Capital Inc.
Original (Japanese)グロース・キャピタル株式会社
4.35%−1.06 ppPure investmentPure investment
Original (Japanese)純投資
Filed  — filing S100ZHKZ